Literature DB >> 15912133

Biphasic neurogenic vasodilatation in the bovine intraocular long posterior ciliary artery: involvement of nitric oxide and an additional unidentified neurotransmitter.

Jill Overend1, William S Wilson, William Martin.   

Abstract

We have investigated the neurogenic factors inducing relaxation in the intraocular segment of the bovine long posterior ciliary artery. In precontracted vessels, electrical field stimulation (EFS, 0.5-128 Hz, 10 s trains) in the presence of guanethidine (30 microM) evoked biphasic relaxation: optimal relaxation for the first and second components occurred at 10 and 50 s, respectively. The first component, but not the second, was abolished by L-NAME (100 microM) or ODQ (3 microM). Relaxation to exogenous CGRP (0.1-300 nM) was inhibited by the CGRP antagonist, CGRP(8-37) (1-5 microM), but neither component of neurogenic relaxation was affected. Preincubation with the sensory nerve excitotoxin, capsaicin (1 microM), had no effect on either the first or second components of neurogenic relaxation. Substance P (0.1 nM-0.1 microM) induced relaxation, but rapid and complete desensitisation occurred within minutes. Neither desensitisation to substance P (0.1 microM) nor incubation with the NK(1) antagonist, L-733,060 (0.3 microM), had any effect on the first or second components of neurogenic relaxation.VIP (0.1 nM-0.3 microM) induced relaxation and this was followed by substantial desensitisation. Neither desensitisation to VIP (0.6 microM) nor treatment with the protease, alpha-chymotrypsin (10 U ml(-1)), had any effect on the first or second components of neurogenic relaxation. The results indicate that nitric oxide mediates the first component of neurogenic relaxation in the bovine intraocular ciliary artery. The neurotransmitter mediating the second component remains to be determined but is unlikely to be CGRP, substance P or VIP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912133      PMCID: PMC1576216          DOI: 10.1038/sj.bjp.0706264

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Calcitonin gene-related peptide mediated neurogenic vasorelaxation in the isolated canine lingual artery.

Authors:  D Kobayashi; K Todoki; S Ozono; E Okabe
Journal:  Jpn J Pharmacol       Date:  1995-04

2.  Inhibition of nitroxidergic nerve function by neurogenic acetylcholine in monkey cerebral arteries.

Authors:  N Toda; K Ayajiki; T Okamura
Journal:  J Physiol       Date:  1997-01-15       Impact factor: 5.182

3.  Inhibition of vasodilator neurotransmission in the sheep middle cerebral artery by VIP antiserum.

Authors:  J D Matthew; R M Wadsworth; A R McPhaden
Journal:  J Auton Pharmacol       Date:  1997-02

4.  Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries.

Authors:  U Simonsen; A García-Sacristán; D Prieto
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

5.  Evidence for functional responses to sensory nerve stimulation of rat small mesenteric veins.

Authors:  A Ahluwalia; P Vallance
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

6.  L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays.

Authors:  G R Seabrook; S L Shepheard; D J Williamson; P Tyrer; M Rigby; M A Cascieri; T Harrison; R J Hargreaves; R G Hill
Journal:  Eur J Pharmacol       Date:  1996-12-12       Impact factor: 4.432

7.  Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.

Authors:  J Garthwaite; E Southam; C L Boulton; E B Nielsen; K Schmidt; B Mayer
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.436

8.  Neurogenic relaxations caused by nicotine in isolated cat middle cerebral arteries.

Authors:  K Ayajiki; T Okamura; N Toda
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

9.  Variable potency of nitrergic-nitrovasodilator relaxations of the mouse anococcygeus against different forms of induced tone.

Authors:  A Gibson; I McFadzean; J F Tucker; C Wayman
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

10.  Localization and activity of haem oxygenase and functional effects of carbon monoxide in the feline lower oesophageal sphincter.

Authors:  L Ny; P Alm; P Ekström; B Larsson; L Grundemar; K E Andersson
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  3 in total

Review 1.  Recent advances in research on nitrergic nerve-mediated vasodilatation.

Authors:  Noboru Toda; Tomio Okamura
Journal:  Pflugers Arch       Date:  2014-10-23       Impact factor: 3.657

2.  Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery.

Authors:  J Overend; W Martin
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

3.  Stimulation of Baroresponsive Parts of the Nucleus of the Solitary Tract Produces Nitric Oxide-mediated Choroidal Vasodilation in Rat Eye.

Authors:  Chunyan Li; Malinda E C Fitzgerald; Nobel Del Mar; Anton Reiner
Journal:  Front Neuroanat       Date:  2016-10-07       Impact factor: 3.856

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.